Drug company Aspen may pay NHS £8 million after investigation alleges illegal deal to hike drug price

14 August 2019 - The drug company Aspen may have to pay the NHS £8 million (€8.7 million ; $9.7 ...

Read more →

Trump’s Canada drug import plan can’t happen without big pharma

13 August 2019 - Distributors see no incentive to export for fear of reprisals. ...

Read more →

Ottawa’s move to cut drug prices may lead to fewer new launches, less R&D

13 August 2019 - Health Canada is fundamentally changing how prescription drugs are priced in Canada.  ...

Read more →

Why America’s biggest charities are owned by pharmaceutical companies

13 August 2019 - Their generosity helps their bottom line. ...

Read more →

Proposed new drug regulations will hurt all Canadians — and Ottawa has been warned

13 August 2019 - Changes which aim to make prescriptions more affordable could shut off entry of new drugs. ...

Read more →

Canadian drug price regulator may be flexible on rare diseases

14 August 2019 - Canada’s patented drug price regulator, set to gain new powers next year, may be “more forgiving” in ...

Read more →

Boston startup signs up millions for lower prescription drug costs

12 August 2019 - Ever had that uneasy feeling at the pharmacy counter when you’re not sure if a prescription drug ...

Read more →

Federal changes to drug prices win praise from patient advocates but spark industry warnings

10 August 2019 - A federal government move to lower drug prices is winning praise from some patient advocates but ...

Read more →

Democratic hopefuls take aim at insurer and pharma profits

11 August 2019 - Senator Bernie Sanders and other progressives seeking the Democratic presidential nomination are zeroing in on pharmaceutical ...

Read more →

AARP unveils giant calculator tallying high prescription drug prices

12 August 2019 - In an unprecedented effort to raise awareness about the need for state solutions to cut drug ...

Read more →

Canadians are hopping mad about Trump’s drug importation plan. Some of them are trying to stop it.

12 August 2019 - Canadians are furious about the Trump administration’s plan to import their prescription drugs. And some of ...

Read more →

Drug maker 'will make $21 billion from treating cystic fibrosis'

12 August 2019 - Vertex is accused of raking in vast profits while making Orkambi unaffordable to NHS. ...

Read more →

Is rate of return pricing a useful approach when value based pricing is not appropriate?

12 August 2019 - The pricing of new health technologies, such as drugs or devices, involves deciding how the economic ...

Read more →

Patient groups push back against Gilead's pricey HIV prevention treatment

7 August 2019 - Gilead Sciences hopes to soon introduce a pricey new pill to prevent HIV in people at risk ...

Read more →

Drug policy experts accuse industry and patient groups of 'fearmongering' with concerns about new drug pricing rule

11 August 2019 - Industry groups and patient advocates are raising concerns about the federal government’s new drug-pricing rules, claiming ...

Read more →